Forskningsoutput per år
Forskningsoutput per år
Forskningsoutput
- 4 Artikel i vetenskaplig tidskrift
- 4 resultat
Sökresultat
-
2022
Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
Wahlin, S., Boman, K., Moran, B., Nodin, B., Gallagher, W. M., Karnevi, E. & Jirström, K., 2022, I: BMC Cancer. 22, 1, 131.Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
Öppen tillgång -
PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer
Olsson Hau, S., Wahlin, S., Cervin, S., Falk, V., Nodin, B., Elebro, J., Eberhard, J., Moran, B., Gallagher, W. M., Karnevi, E. & Jirström, K., 2022, I: Journal of Pathology: Clinical Research. 8, 1, s. 65-77Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
Öppen tillgång -
2020
Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: Implications for risk stratification of bladder cancer
Andersson, N., Ohlsson, J., Wahlin, S., Nodin, B., Boman, K., Lundgren, S. & Jirström, K., 2020 okt. 7, I: Biomarker research. 8, 1, 51.Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
Öppen tillgång -
2019
Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens
Wahlin, S., Nodin, B., Leandersson, K., Boman, K. & Jirström, K., 2019, I: OncoImmunology. 8, 11, e1644108.Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
Öppen tillgång